The cohesive impact of DNMTis across gynecological cancers lies in their ability to reprogram the TIME through interconnected mechanisms: enhancing CTA and HLA class I expression, amplifying IFN signaling, polarizing macrophages toward tumoricidal phenotypes, and boosting chemokine-driven immune cell infiltration. This evidence concerns the gene IFNA1 and female reproductive organ cancer.